Table of Contents Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Research Report 2018 1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview 1.1 Product Overview and Scope of Chemotherapy-Induced Nausea and Vomiting Drugs 1.2 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Type (Product Category) 1.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 1.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Market Share by Type (Product Category) in 2017 1.2.3 Existing Drugs 1.2.4 Akynzeo (Netupitant-Palonosetron FDC) 1.2.5 Aloxi (Palonosetron) 1.2.6 Emend (Aprepitant) 1.2.7 Kytril Generic (Granisetron) 1.2.8 Zofran Generic (Ondansetron) 1.2.9 Pipeline Drugs 1.2.10 SUSTOL (Granisetron Injection extended release) 1.2.11 Rolapitant 1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Application 1.3.1 Chemotherapy-Induced Nausea and Vomiting Drugs Consumption (Sales) Comparison by Application (2013-2025) 1.3.2 Serotonin Receptor Antagonists 1.3.3 NK1 Receptor Antagonists 1.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Region (2013-2025) 1.4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 1.4.2 North America Status and Prospect (2013-2025) 1.4.3 Europe Status and Prospect (2013-2025) 1.4.4 China Status and Prospect (2013-2025) 1.4.5 Japan Status and Prospect (2013-2025) 1.4.6 Southeast Asia Status and Prospect (2013-2025) 1.4.7 India Status and Prospect (2013-2025) 1.5 Global Market Size (Value) of Chemotherapy-Induced Nausea and Vomiting Drugs (2013-2025) 1.5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Status and Outlook (2013-2025) 1.5.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Capacity, Production Status and Outlook (2013-2025) 2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Competition by Manufacturers 2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Capacity, Production and Share by Manufacturers (2013-2018) 2.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Capacity and Share by Manufacturers (2013-2018) 2.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production and Share by Manufacturers (2013-2018) 2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Share by Manufacturers (2013-2018) 2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Average Price by Manufacturers (2013-2018) 2.4 Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base Distribution, Sales Area and Product Type 2.5 Chemotherapy-Induced Nausea and Vomiting Drugs Market Competitive Situ

List of Tables and Figures Figure Picture of Chemotherapy-Induced Nausea and Vomiting Drugs Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025) Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Market Share by Types (Product Category) in 2017 Figure Product Picture of Existing Drugs Table Major Manufacturers of Existing Drugs Figure Product Picture of Akynzeo (Netupitant-Palonosetron FDC) Table Major Manufacturers of Akynzeo (Netupitant-Palonosetron FDC) Figure Product Picture of Aloxi (Palonosetron) Table Major Manufacturers of Aloxi (Palonosetron) Figure Product Picture of Emend (Aprepitant) Table Major Manufacturers of Emend (Aprepitant) Figure Product Picture of Kytril Generic (Granisetron) Table Major Manufacturers of Kytril Generic (Granisetron) Figure Product Picture of Zofran Generic (Ondansetron) Table Major Manufacturers of Zofran Generic (Ondansetron) Figure Product Picture of Pipeline Drugs Table Major Manufacturers of Pipeline Drugs Figure Product Picture of SUSTOL (Granisetron Injection extended release) Table Major Manufacturers of SUSTOL (Granisetron Injection extended release) Figure Product Picture of Rolapitant Table Major Manufacturers of Rolapitant Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Consumption (K Units) by Applications (2013-2025) Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Consumption Market Share by Applications in 2017 Figure Serotonin Receptor Antagonists Examples Table Key Downstream Customer in Serotonin Receptor Antagonists Figure NK1 Receptor Antagonists Examples Table Key Downstream Customer in NK1 Receptor Antagonists Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025) Figure North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) Status and Outlook (2013-2025) Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Capacity, Production (K Units) Status and Outlook (2013-2025) Figure Global Chemotherapy-Induced Nausea and Vomiting D